ChemoCentryx

RAPT Therapeutics

This biopharmaceutical company develops oral small-molecule therapies for patients with inflammatory diseases and cancer.

Sitryx

This biopharmaceutical company develops oral small molecule medicines that target immune cell metabolism to treat patients with chronic autoimmune and inflammatory diseases.

Horizon Pharma

This company develops and commercialises medicines for patients with rare, autoimmune and severe inflammatory diseases.

Pharmacyclics

This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.

Kezar Life Sciences

This clinical-stage biopharmaceutical company develops small-molecule therapeutics for patients with autoimmune diseases and inflammatory conditions.

Coherus

This biopharmaceutical company develops and commercialises immuno-oncology therapies and biosimilar medicines for patients living with cancer and other serious inflammatory diseases.

Principia Biopharma

The company develops oral small molecule therapies for patients with immune-mediated diseases and cancer.

Landos Biopharma

This company develops oral medicines for patients with autoimmune diseases, specifically targeting inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.